D.E. Shaw & Co’s Oric Pharmaceuticals ORIC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-98,433
| Closed | -$906K | – | 3329 |
|
2023
Q4 | $906K | Sell |
98,433
-209,046
| -68% | -$1.92M | ﹤0.01% | 2117 |
|
2023
Q3 | $1.86M | Sell |
307,479
-145,770
| -32% | -$882K | ﹤0.01% | 1750 |
|
2023
Q2 | $3.52M | Sell |
453,249
-125,054
| -22% | -$970K | ﹤0.01% | 1439 |
|
2023
Q1 | $3.3M | Sell |
578,303
-24,484
| -4% | -$140K | ﹤0.01% | 1581 |
|
2022
Q4 | $3.55M | Buy |
602,787
+68,899
| +13% | +$406K | ﹤0.01% | 1670 |
|
2022
Q3 | $1.71M | Buy |
533,888
+27,901
| +6% | +$89.3K | ﹤0.01% | 2211 |
|
2022
Q2 | $2.27M | Buy |
505,987
+261,088
| +107% | +$1.17M | ﹤0.01% | 2171 |
|
2022
Q1 | $1.31M | Buy |
+244,899
| New | +$1.31M | ﹤0.01% | 2706 |
|
2021
Q2 | – | Sell |
-9,812
| Closed | -$240K | – | 3699 |
|
2021
Q1 | $240K | Buy |
+9,812
| New | +$240K | ﹤0.01% | 2736 |
|